Mitrix.bio develops whole-body mitochondrial transfusion (mitotherapy), addressing Alzheimer's, Parkinson's, heart disease, sarcopenia, and other diseases of aging. They grow "young" mitochondria in external bioreactors, then transfuse them into the body where they are taken up by cells and immediately start boosting ATP production, enabling cells to regenerate to a more youthful state.